Related references
Note: Only part of the references are listed.Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial
Chengcheng Guo et al.
JAMA NETWORK OPEN (2023)
Long-term Outcome With Prolonged Use of Interferon-alpha Administered Intermittently for Metastatic Renal Cell Carcinoma: A Phase II Study
Minna Kankuri-tammilehto et al.
ANTICANCER RESEARCH (2023)
Type I interferon-mediated tumor immunity and its role in immunotherapy
Renren Yu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2022)
Co-occurrence of CDKN2A/B and IFN-I homozygous deletions correlates with an immunosuppressive phenotype and poor prognosis in lung adenocarcinoma
Yuan Peng et al.
MOLECULAR ONCOLOGY (2022)
MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasis
Francisco M. Barriga et al.
NATURE CANCER (2022)
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer
Stanley Gutiontov et al.
SCIENTIFIC REPORTS (2021)
Comprehensive Analysis Revealed that CDKN2A is a Biomarker for Immune Infiltrates in Multiple Cancers
Zheng Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Second surgery for progressive glioblastoma: a multi-centre questionnaire and cohort-based review of clinical decision-making and patient outcomes in current practice
P. M. Brennan et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
The prognostic significance of p16 expression pattern in diffuse gliomas
Jin Woo Park et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2021)
Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus
Tiphaine Delaunay et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Interferon α in cancer immunoediting: From elimination to escape
Paolo Vidal
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2020)
A central role for canonical PRC1 in shaping the 3D nuclear landscape
Shelagh Boyle et al.
GENES & DEVELOPMENT (2020)
The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature
Victor M. Lu et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer
Haiwei Wang et al.
Aging-US (2020)
Loss of CDKN2A at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression
Wei Liu et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2020)
Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma
Lucia Cottone et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2020)
Empowering therapeutic antibodies with IFN-α for cancer immunotherapy
Jun Guo et al.
PLOS ONE (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications
Eleonora Arico et al.
CANCERS (2019)
Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance
Zhenqing Ye et al.
CLINICAL CANCER RESEARCH (2018)
Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer
Pascale Kundig et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making
Thomas S. Worst et al.
SCIENTIFIC REPORTS (2018)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
The type I interferons: Basic-concepts and clinical relevance in immune-mediated inflammatory diseases
Consuelo M. Lopez de Padilla et al.
GENE (2016)
CDKN2A Loss Is Associated With Shortened Overall Survival in Lower-Grade (World Health Organization Grades II-III) Astrocytomas
Gerald F. Reis et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Immune Checkpoint Blockade and Interferon-α in Melanoma
Imran Rafique et al.
SEMINARS IN ONCOLOGY (2015)
Glioma
Michael Weller et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry
Suvendu Purkait et al.
NEUROPATHOLOGY (2013)
IFN-α in the Treatment of Melanoma
Ahmad A. Tarhini et al.
JOURNAL OF IMMUNOLOGY (2012)
Differing Patterns of Circulating Regulatory T Cells and Myeloid-derived Suppressor Cells in Metastatic Melanoma Patients Receiving Anti-CTLA4 Antibody and Interferon-α or TLR-9 Agonist and GM-CSF With Peptide Vaccination
Ahmad A. Tarhini et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Fluorescence in situ hybridization with high-complexity repeat-free oligonucleotide probes generated by massively parallel synthesis
Shelagh Boyle et al.
CHROMOSOME RESEARCH (2011)
p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors
C. Romagosa et al.
ONCOGENE (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Role of Type 1 IFNs in Antiglioma Immunosurveillance-Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans
Mitsugu Fujita et al.
CLINICAL CANCER RESEARCH (2010)
Intratumoral Heterogeneity of Immunohistochemical Marker Expression in Breast Carcinoma A Tissue Microarray-based Study
Aziza Nassar et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2010)
Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
Steven M. Pollard et al.
CELL STEM CELL (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Interferon-α and cancer:: Mechanisms of action and new perspectives of clinical use
Maria Ferrantini et al.
BIOCHIMIE (2007)
The regulation of INK4/ARF in cancer and aging
William Y. Kim et al.
CELL (2006)
Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all
Jesus Gil et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme
T Kamiryo et al.
JOURNAL OF NEUROSURGERY (2002)
Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype
K Milde-Langosch et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Share Paper
